• Chemicals
• Discovery / R&D
• Generics
• Market Trends
• Pharma Industry Trends
• Pricing & Reimbursement
• Regulatory
• Sales & Marketing
• Therapeutic

M&A in pharma

Explores the merits of mega-deal in contrast to a more measured portfolio growth strategy

BioGenerics is an umbrella term used to define the market for bioequivalent products based on the same biological substance used in off-patent biologics. The BioGeneric market is set to develop slowly in the major pharmaceutical markets, as a result of regulatory hurdles and continued protectionism from patented biopharmaceutical marketers. Once the market does begin to evolve, the biogeneric companies entering the market early will derive significant value.

Using a proprietary methodology, this Consensus Market Model report analyses the potential market for BioGenerics products by the year 2010. The 50 page report will provide you with the necessary insight to make informed decisions about this extremely exciting market.

'Biopharmaceuticals are set to win market share not only in monetary terms but also in numbers of products on the market'

Key findings of this report
A Consensus Market Model forecast for the global BioGenerics market in 2010 of $2.3 billion

Current off-patent blockbusters including erythropoietin, represent an excellent opportunity

Significant obstacles associated with manufacturing and marketing BioGenerics has reduced the number of potential BioGenerics companies to less than ten

A key market event is the launch of Omnitrop in Australia in late 2005 or early 2006

Why read this report
Understand key market conditions that underpin the future of BioGeneric products
Assess the current market research and analysis from a broad range of sources
Learn how regulatory authorities are shaping the market
Gain insight into which companies are working in this area

Base your forecast on key market conditions -

not potential headline figures

Executive Summary
Market Analysis
Market Forecast

1. Market Definitions & Scope
Market definitions
Market scope
Market evolution

2. Market Sizing
Current market reach
Current market size
R&D activity

3. Market Segmentation
Key geographies
Key market segments
Key companies

4. Key Market Trends
Historical trends
Future trend projections

5. Critical Market Events
First key event: Approval and launch of first biogeneric, Omnitrop(e)
Second key event: US clarification of biogenerics regulation
Third key event: Growing number of patent expiries

6. Future Market Scenarios
Best case market scenario
Worst case market scenario
Most likely market scenario

7. Future Market Forecasts
Forecasting methodology
Base case forecast
Best and worse case scenarios
Sources